Cover Image

Chimeric Antigen Receptor (CAR)-T Cell Therapy for Non-Hodgkin's Lymphoma

This review focuses on the use of chimeric antigen receptor (CAR)-T cell therapy to treat non-Hodgkin's lymphoma (NHL), a classification of heterogeneous malignant neoplasms of the lymphoid tissue. Despite various conventional and multidrug chemotherapies, the poor prognosis for NHL patients re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Maria Giraudo (Author), Zachary Jackson (Author), Indrani Das (Author), Olubukola Abiona (Author), David Wald (Author)
Format:	Book
Published:	Case Western Reserve University, 2024-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
by: Zixun Yin, et al.
Published: (2021)

Chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma: opportunities and challenges
by: Shinichi Makita, et al.
Published: (2019)

Site-specific transgene integration in chimeric antigen receptor (CAR) T cell therapies
by: Hamed Dabiri, et al.
Published: (2023)

Chimeric antigen receptor (CAR) T-cell therapy: Harnessing extracellular vesicles for enhanced efficacy
by: Beatrice Spokeviciute, et al.
Published: (2024)

Cancer stem cell-targeted chimeric antigen receptor (CAR)-T cell therapy: Challenges and prospects
by: Javad Masoumi, et al.
Published: (2021)

Recent advances and clinical pharmacology aspects of Chimeric Antigen Receptor (CAR) T‐cellular therapy development
by: Johannes Kast, et al.
Published: (2022)

TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy
by: Zakaria Grada, et al.
Published: (2013)

Engineering T cells with hypoxia-inducible chimeric antigen receptor (HiCAR) for selective tumor killing
by: Qibin Liao, et al.
Published: (2020)

Chimeric antigen receptor T cell therapy for multiple myeloma
by: Kana Hasegawa, et al.
Published: (2019)

Current status and future prospects of chimeric antigen receptor-T cell therapy in lymphoma research: A bibliometric analysis
by: Lijia Ou, et al.
Published: (2023)

The FDA's Regulatory Framework for Chimeric Antigen Receptor‐T Cell Therapies
by: Peter Marks
Published: (2019)

Biomarkers in individualized management of chimeric antigen receptor T cell therapy
by: Mengyi Du, et al.
Published: (2020)

Chimeric antigen receptor (CAR) T cells for the treatment of a kidney transplant patient with post-transplant lymphoproliferative disorder (PTLD)
by: Kathryn Kline, et al.
Published: (2023)

Chimeric antigen receptor-natural killer (CAR-NK) cell immunotherapy: A bibliometric analysis from 2004 to 2023
by: Wangshu Li, et al.
Published: (2024)

New advances in leukaemia immunotherapy by the use of Chimeric Artificial Antigen Receptors (CARs): state of the art and perspectives for the near future
by: Cribioli Elisabetta, et al.
Published: (2011)

Novel Targeted Agents in Hodgkin and Non-Hodgkin Lymphoma Therapy
by: Natalie S. Grover, et al.
Published: (2015)

Nanotechnology in Advancing Chimeric Antigen Receptor T Cell Therapy for Cancer Treatment
by: Xuejia Kang, et al.
Published: (2024)

Quantitative Systems Pharmacology Model of Chimeric Antigen Receptor T‐Cell Therapy
by: Deni Hardiansyah, et al.
Published: (2019)

Bench‐to‐bedside translation of chimeric antigen receptor (CAR) T cells using a multiscale systems pharmacokinetic‐pharmacodynamic model: A case study with anti‐BCMA CAR‐T
by: Aman P. Singh, et al.
Published: (2021)

Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
by: Theodora Katopodi, et al.
Published: (2023)

The Past, Present, and Future of Clinically Applied Chimeric Antigen Receptor-T-Cell Therapy
by: Yuki Fujiwara, et al.
Published: (2022)

Chimeric Antigen Receptor-T Cells: A Pharmaceutical Scope
by: Alejandrina Hernández-López, et al.
Published: (2021)

Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†
by: Zhang Xu, et al.
Published: (2019)

The CAR macrophage cells, a novel generation of chimeric antigen-based approach against solid tumors
by: Kaveh Hadiloo, et al.
Published: (2023)

Sustained efficacy of chimeric antigen receptor T-cell therapy in central nervous system lymphoma: a systematic review and meta-analysis of individual data
by: Jing Zhou, et al.
Published: (2024)

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer
by: Ilnaz Rahimmanesh, et al.
Published: (2021)

Surgery for non-Hodgkin's lymphoma
by: Elroy Patrick Weledji, et al.
Published: (2015)

Sculpting nursing resilience: Transforming lives, nurturing ethics in chimeric antigen receptor T‐cell therapy
by: Pranay Bende
Published: (2024)

Efficacy and Safety of Innovative Experimental Chimeric Antigen Receptor (CAR) T-cells versus Axicabtagene ciloleucel (Yescarta) for the Treatment of Relapsed/Refractory Large B-Cell Lymphoma (LBCL): Matching Adjusted Indirect Comparisons (MAICs) and Systematic Review
by: Bayarmagnai Weinstein, et al.
Published: (2021)

Chimeric antigen receptor engineered cells and their clinical application in infectious disease
by: Chen Qian, et al.
Published: (2022)

PSCA is a target of chimeric antigen receptor T cells in gastric cancer
by: Di Wu, et al.
Published: (2020)

CLINICAL-STATISTICAL ANALYZE OF THE PROGNOSTIC VALUE OF KI-67 ANTIGEN IN CERVICO-FACIAL NON-HODGKIN'S LYMPHOMAS
by: Andrei Nicolau, et al.
Published: (2015)

ORAL AND MAXILLOFACIAL NON-HODGKIN'S LYMPHOMAS
by: Andrei Nicolau, et al.
Published: (2018)

Non-Hodgkin's Lymphoma of Parotid Gland
by: Sanat Kumar Bhuyan, et al.
Published: (2011)

DIAGNOSIS OF CHILDHOOD NON-HODGKIN LYMPHOMA
by: Adriana Sărsan, et al.
Published: (2008)

An unusual presentation of non-hodgkin's lymphoma
by: Vishwaraj Baswaraj Tadakal, et al.
Published: (2020)

Radioimmunotherapy in Non-Hodgkin's Lymphoma: Retrospective Adverse Event Profiling of Zevalin and Bexxar
by: Christos Sachpekidis, et al.
Published: (2019)

Sudden-onset painful eruption of the hands: A cutaneous chimeric antigen receptor T-cell therapy reaction
by: Jimena A. Miranda, MD, et al.
Published: (2023)

Harnessing Biomaterials for Safeguarding Chimeric Antigen Receptor T Cell Therapy: An Artful Expedition in Mitigating Adverse Effects
by: Zhaozhao Chen, et al.
Published: (2024)

Current approaches in the grading and management of cytokine release syndrome after chimeric antigen receptor T-cell therapy
by: Riegler LL, et al.
Published: (2019)